OSAM
PCVX icon

O'Shaughnessy Asset Management’s Vaxcyte PCVX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,884
Closed -$400K – 2370
2024
Q4 		$400K Sell
4,884
-2,062
-30% -$205K ﹤0.01% 1379
2024
Q3 		$786K Buy
6,946
+2,681
+63% +$242K 0.01% 1013
2024
Q2 		$322K Sell
4,265
-438
-9% -$29.8K ﹤0.01% 1328
2024
Q1 		$321K Buy
+4,703
New +$326K ﹤0.01% 1289
2021
Q3 		– Sell
-426
Closed -$10K – 2828
2021
Q2 		$10K Buy
+426
New +$8.72K ﹤0.01% 1999

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

O'Shaughnessy Asset Management's PCVX Position: Q1 2025 in Review

O'Shaughnessy Asset Management sold out of Vaxcyte (PCVX) in Q1 2025, closing a stake of 4,884 shares — an estimated $400K sold.

O'Shaughnessy Asset Management first reported a position in PCVX in Q2 2021 and held it in 5 quarters. The position peaked at $786K in Q3 2024. 315 funds tracked by Wall St. Rank hold PCVX as of Q1 2025.

  • O'Shaughnessy Asset Management reported no remaining Vaxcyte position as of Q1 2025 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 4,884 Vaxcyte shares in Q1 2025, an estimated $400K.
  • O'Shaughnessy Asset Management first reported a position in Vaxcyte in Q2 2021 and held it in 5 quarters.
  • O'Shaughnessy Asset Management's Vaxcyte position peaked at $786K in Q3 2024.
  • 315 funds tracked by Wall St. Rank held Vaxcyte as of Q1 2025.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2025, filed 13 May 2025.